Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Drugs & Aging|November 9, 2021
Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and ModelsSweilem B Al Rihani, Malavika Deodhar, Lucy I Darakjian, et al.
Journal of Patient Safety|May 17, 2021
Longitudinal Association of a Medication Risk Score With Mortality Among Ambulatory Patients Acquired Through Electronic Health Record DataAmanda Rondinelli Ratigan, Veronique Michaud, Jacques Turgeon, et al.
Pharmaceutics|September 5, 2019
Impact of GSTA1 Polymorphisms on Busulfan Oral Clearance in Adult Patients Undergoing Hematopoietic Stem Cell TransplantationVeronique Michaud, My Tran, Benoit Pronovost, et al.
Expert Opinion on Drug Safety|November 28, 2025
CYP450 activity, drug interactions, and genetic polymorphisms: clinical relevance for the new selective cardiac myosin inhibitorsMilind Y Desai, Veronique Michaud, David Thacker, et al.
Medicina (Kaunas, Lithuania)|January 21, 2023
Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient FallJoshua Russell, Meghan J Arwood, Nicole M Del Toro-Pagán, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|November 12, 2013
Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapyParvaz Madadi, Ursula Amstutz, Michael Rieder, et al.
Journal of Personalized Medicine|June 24, 2022
Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case ReportSelina Muhn, Nishita Shah Amin, Chandni Bardolia, et al.
Journal of Personalized Medicine|November 27, 2021
Use of Drug Claims Data and a Medication Risk Score to Assess the Impact of CYP2D6 Drug Interactions among Opioid Users on Healthcare CostsVeronique Michaud, Ravil Bikmetov, Matt K Smith, et al.
Therapeutic Drug Monitoring|July 18, 2015
Clinical Practice Recommendations on Genetic Testing of CYP2C9 and VKORC1 Variants in Warfarin TherapyKaitlyn Shaw, Ursula Amstutz, Richard B Kim, et al.
AIDS (London, England)|July 22, 2010
HIV-1 subtype B and C integrase enzymes exhibit differential patterns of resistance to integrase inhibitors in biochemical assaysTamara Bar-Magen, Daniel A Donahue, Emily I McDonough, et al.
Pageof 7